Basilea Pharmaceutica Ltd logo

Basilea Pharmaceutica Ltd - Registered Shares

NEW
LTS:0QNA (Switzerland)   Registered Shares
CHF 53.08 +0.076 (+0.14%) Aug 14
16.81
P/B:
5.08
Market Cap:
CHF 657.20M ($ 807.71M)
Enterprise V:
CHF 586.62M ($ 720.96M)
Volume:
7.14K
Avg Vol (2M):
9.38K
Trade In:
Volume:
7.14K
Avg Vol (2M):
9.38K

Basilea Pharmaceutica Ltd (LTS:0QNA) Dividend

Basilea Pharmaceutica Ltd (LTS:0QNA) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -0.9%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: LTS:0QNA Dividend

Does Basilea Pharmaceutica Ltd (LTS:0QNA) pay a dividend?

Basilea Pharmaceutica Ltd (LTS:0QNA) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Basilea Pharmaceutica Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Basilea Pharmaceutica Ltd has returned capital to shareholders via buybacks at a rate of -0.9% over the past 3 years.

What are dividend-paying alternatives to Basilea Pharmaceutica Ltd?

For dividend-paying alternatives in Basilea Pharmaceutica Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.